Thompson Davis & Co’s Zimmer Biomet ZBH Stock Holding History

Thompson Davis & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$3K	Hold	26	–	–	0.01%	641
2018 Q2	$3K	Hold	26	–	–	0.01%	588
2018 Q1	$3K	Hold	26	–	–	0.01%	550
2017 Q4	$3K	Hold	26	–	–	0.01%	589
2017 Q3	$3K	Hold	26	–	–	0.01%	962
2017 Q2	$3K	Sell	26 -476	-95%	-$56.4K	﹤0.01%	952
2017 Q1	$59K	Hold	502	–	–	0.08%	225
2016 Q4	$50K	Hold	502	–	–	0.08%	238
2016 Q3	$63K	Hold	502	–	–	0.11%	196
2016 Q2	$59K	Buy	502 +476	+1,831%	+$53.9K	0.09%	213
2016 Q1	$3K	Buy	+26	New	+$2.52K	﹤0.01%	904
2015 Q3	–	Sell	-110	Closed	-$12K	–	1259
2015 Q2	$12K	Sell	110 -72	-40%	-$7.97K	0.01%	679
2015 Q1	$21K	Sell	182 -117	-39%	-$13.3K	0.03%	517
2014 Q4	$33K	Buy	+299	New	+$31.5K	0.04%	375

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Thompson Davis & Co's ZBH Position: Q3 2018 in Review

Thompson Davis & Co held its Zimmer Biomet (ZBH) position steady in Q3 2018 at 26 shares worth $3K. The position accounts for 0.01% of the portfolio, ranked #641.

Thompson Davis & Co first reported a position in ZBH in Q4 2014 and has held it in 14 quarters since. The position peaked at $63K in Q3 2016. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

Thompson Davis & Co held 26 shares of Zimmer Biomet worth $3K as of Q3 2018.
Thompson Davis & Co left its Zimmer Biomet share count unchanged in Q3 2018.
Zimmer Biomet made up 0.01% of Thompson Davis & Co's portfolio in Q3 2018, its #641 holding.
Thompson Davis & Co first reported a position in Zimmer Biomet in Q4 2014 and has held it in 14 quarters since.
Thompson Davis & Co's Zimmer Biomet position peaked at $63K in Q3 2016.
891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.